[1]Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61:69-90.
[2]Wu ZH,Liu Y,Wang HJ,et al.Expression and clinical significance of lysyl oxidase-like 2 in Kazakh esophageal squamous cell carcinoma[J].Chinese Journal of Cancer Prevention and Treatment,2017,24(16):1142-1147.[吴振华,刘翼,王洪江,等.新疆哈萨克族ESCC组织LOXL2表达及临床意义[J].中华肿瘤防治杂志,2017,24(16):1142-1147.]
[3]Florell SR,Coffin CM,Holden JA,et al.Preservation of RNA for functional genomic studies:A multidisciplinary tumor bank protocol[J].Med Pathol,2001,14(2):116-128.
[4]Salimi-Asl M,Mozdarani H,Kadivar M.Up-regulation of miR-21 and 146a expression and increased DNA damage frequency in a mouse model of polycystic ovary syndrome(PCOS)[J].Bioimpacts,2016,6(2):85-91.
[5]Campbell LD,Betsou F,Garcia DL,et al.Development of the ISBER best practices for repositories:Collection,storage,retrieval and distribution of biological materials for research[J].Biopreserv Biobank,2012,10(2):232-233.
[6]Ji JF.Standardization of cancer biobank in precision medicine era[J].Journal of Zhejiang University(Medical Sciences),2016,45(4):331-334.[季加孚.精准医学时代肿瘤样本库的规范化建设[J].浙江大学学报(医学版),2016,45(4):331-334.]
[7]Liu YH,Hu Y,Zhang QQ,et al.Standardization of project management process in biobank[J].Chinese Medicinal Biotechnology,2017,12(4):372-374.[刘艳红,胡月,张倩倩,等.生物样本库项目管理流程的规范化[J].中国医药生物技术,2017,12(4):372-374.]
[8]Lin Min,Jiang Yan,Zhang Yanan,et al.Application status of the biobank and biospecimen[J].Modern Oncology,2016,24(9):1490-1493.[林敏,姜岩,张亚南,等.生物样本库及样本应用现状[J].现代肿瘤医学,2016,24(9):1490-1493.]
[9]Xue Q,Li ZP,Xiang YJ,et al.The biobank construction in comprehensive hospital[J].Hospital Administration Journal of Chinese People's Liberation Army,2015,22(12):1178-1180.[薛芊,李张鹏,项耀钧,等.综合性医院生物样本库建设的思考[J].解放军医院管理杂志,2015,22(12):1178-1180.]
[10]Blutke A,Wanke R.Sampling strategies and processing of biobank tissue samples from porcine biomedical models[J].J Vis Exp,2018,133:e57276.
[11]Shi G,Dai QH,Men TN,et al.The role of scientific research management department in the construction of biobank[J].Chinese Journal of Medical Science Research Management,2017,30(4):244-247,254.[时钢,代庆海,门天男,等.科研管理部门在生物样本库建设中的作用[J].中华医学科研管理杂志,2017,30(4):244-247,254.]
[12]Wang GB.Value proposition of bio specimen information under precise medical back-ground[J].China Science & Technology Resources Review,2017,49(4):12-18.[王戈波.精准医疗背景下生物样本信息的价值初探[J].中国科技资源导刊,2017,49(4):12-18.]
[13]Wu ML,Wang ZQ,Luo K,et al.The controllability collection and quality management of clinical biobank for blood biospecimen[J].Translational Medicine Journal,2016,5(6):327-332.[吴曼丽,王柱清,罗凯,等.临床生物样本库血液样本的可控性采集和质量管理[J].转化医学杂志,2016,5(6):327-332.]
[14]Li HY,Ni MY,Wang XM,et al.Analysis for the clinical biobanks sustainable development and influence factors[J].Chinese Journal of Medical Science Research Management,2017,30(2):85-89.[李海燕,倪明宇,王晓民,等.临床生物样本库发展及其影响因素分析[J].中华医学科研管理杂志,2017,30(2):85-89.]
[15]Xu JM,Zhou YF,Zhang XY,et al.Analysis of current situation of management and application of biobank in China[J].Practical Journal of Organ Transplantation(Electronic Version),2017,5(6):448-451.[许靖曼,周一峰,张小燕,等.中国生物样本库资源管理与应用现状分析[J].实用器官移植电子杂志,2017,5(6):448-451.]
[16]Guo D,Yang WH,Xu YC.Construction and development of the information system of clinical biobank[J].Medical Journal of Peking Union Medical College Hospital,2018,9(1):81-86.[郭丹,杨文航,徐英春.临床生物样本库信息系统建设与发展[J].协和医学杂志,2018,9(1):81-86.]